2016 Revision of WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, Non-Hematopathologist, (Part 2 of 2)
November 17, 2016 9:00am CST
Review the most important changes to the WHO hematopathology classification system as part of the 2016 revision. Emphasis will be placed on presenting the information so that it is relevant and understandable by non-hematopathologists and laboratory staff. This will be a two-part presentation, with the first lecture covering lymphoid neoplasms and the second presentation covering myeloid and precursor neoplasms. September 15, 2016 was part one of the series.
- Understand the need for the 2016 revision to the 2008 WHO hematopathology classification system.
- Review pertinent changes involving lymphoid neoplasms in a manner understandable by general pathologists and laboratory staff.
- Illustrate important situations where advanced testing (e.g. IHC, molecular, FISH) may be helpful in further distinguishing hematopoietic neoplasms, which had been difficult to classify or confirm with certainty in the past.
Philip Ferguson, MD is a practicing pathologist in private practice located in Arkansas. He has a diverse training background that includes an undergraduate degree in mechanical engineering, post-graduate training in internal medicine, and board certifications in anatomic pathology, clinical pathology, and hematopathology. His professional interests center on educational resource development for pathologists and trainees, and use of immunohistochemistry and molecular diagnostics in surgical pathology. Dr. Ferguson launched one of the first widespread internet educational tools for pathology residents to prepare for their board examination, PathMD (www.PathMD.com), which is now the Leica tool PathLead. Dr. Ferguson also serves as a state commissioner for the College of American Pathologists' Accreditation and Laboratory Improvement Program and is also member of the Global Advisory Board for Leica Biosystems. Dr. Ferguson has published several publication of late including ‘Effects of a Multidisciplinary Approach to Improve Volume of Diagnostic Material in CT-Guided Lung Biopsies’ in 2015.